Authors

• Lucio Calandriello (ORCID: https://orcid.org/0000-0002-0280-7348)
• Marc Sylva (ORCID: https://orcid.org/0000-0002-2315-5908)
• Samantha Ellis (ORCID: https://orcid.org/0000-0002-4807-9358)
• Yuben Moodley (ORCID: https://orcid.org/0000-0002-0777-1196)
• I Glaspole
• Christopher Grainge (ORCID: https://orcid.org/0000-0002-6565-9928)
• Nicole Goh (ORCID: https://orcid.org/0000-0003-2065-4346)
• W. Cooper
• Christopher Zappala (ORCID: https://orcid.org/0009-0008-7390-8788)
• P. Hopkins
• Paul N. Reynolds (ORCID: https://orcid.org/0000-0002-2273-1774)
• Gregory Peter Keir
• John A. Mackintosh (ORCID: https://orcid.org/0000-0002-5254-4144)
• D Lynch
• Annabelle Mahar (ORCID: https://orcid.org/0000-0003-2268-9737)
• Helen Jo (ORCID: https://orcid.org/0000-0002-9485-1441)
• Simon L. F. Walsh
• Athol U. Wells
• Stephen M. Humphries
• Tamera J. Corte

Institutions

• University of Parma (IT)
• The University of Sydney (AU)
• Royal Adelaide Hospital (AU)
• The University of Queensland (AU)
• The University of Melbourne (AU)
• The University of Western Australia (AU)
• Royal Brisbane and Women's Hospital (AU)
• Royal Prince Alfred Hospital (AU)
• John Hunter Hospital (AU)
• Princess Alexandra Hospital (AU)
• The Alfred Hospital (AU)
• Agostino Gemelli University Polyclinic (IT)
• National Jewish Health (US)
• Royal Brompton Hospital (GB)
• Institute for Breathing and Sleep (AU)
• Advanced Radiation Therapy (United States) (US)
• Prince Charles Hospital (AU)
• Alfred Health (AU)
• Austin Health (AU)
• National Health and Medical Research Council (AU)
• Imperial College London (GB)
• University of Colorado Denver (US)

Publication Details

Journal

Respirology

Published

2026-01-08

DOI

https://doi.org/10.1002/resp.70196

Citations

1

Primary Topic

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Type

article

Field-Weighted Citation Impact

36.44

Funders

• Bristol-Myers Squibb
• Lung Foundation Australia
• National Health and Medical Research Council